According to BioMarin Pharmaceutical's latest financial reports the company's current earnings are C$2.75 Billion. In 2023 the company made an earning of C$0.26 Billion, an increase over its 2022 earnings that were of C$0.21 Billion. The earnings displayed on this page is the company's Pretax Income.